Meeting
2020 ASCO Virtual Scientific Program
Diagnostic yield of germline genetic testing following tumor testing in prostate cancer patients.
Authors
Kingshuk Das
Invitae, San Francisco, CA
Kingshuk Das , Stephen E Lincoln , Nhu Ngo , Daniel Esteban Pineda Alvarez , Shan Yang , Scott T. Michalski , Sarah M. Nielsen , Edward D. Esplin , Robert Luke Nussbaum
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Risk Reduction, and Genetics
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1591)
DOI
10.1200/JCO.2020.38.15_suppl.1591
Abstract #
1591
Poster Bd #
83
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Inherited pathologic mutations and family history in patients with prostate cancer.
First Author: Shuwen Lin
Poster
2024 ASCO Genitourinary Cancers Symposium
Challenges in patient-centered germline testing delivery for veterans with advanced prostate cancer (APC).
First Author: Daniel H Kwon
Poster
2023 ASCO Genitourinary Cancers Symposium
Germline testing for men with prostate cancer: Need to broaden the indications in Europe?
First Author: Elena Trevisi
Poster
2022 ASCO Genitourinary Cancers Symposium
Outcomes of an advanced practice nurse (APN)-led cancer genetics service.
First Author: Lisa Aiello